Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ (29,437)	$ 9,180	$ (9,040)	$ (56,780)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	751	2,053	2,203	1,605
Stock-based compensation	171	243	604	998
Deferred income taxes	2	(2)	3	(98)
Goodwill and intangible assets impairment	21,090			52,434
Other-than-temporary impairment on investment securities	127	61	23	413
Net realized (gains) losses on sales and redemptions of investments	105	(32)	(3,265)	(228)
Investment income and equity in earnings from limited partnership interests		(399)
Other	134	280	330	397
Change in:
Premiums and fees receivable	(824)	(937)	(3,915)	817
Loss and loss adjustment expense reserves	1,012	5,026	9,824	(4,774)
Unearned premiums and fees	(308)	891	4,628	(1,791)
Litigation settlement				(46)
Other	(149)	1,391	2,409	884
Net cash provided by (used in) operating activities	(7,326)	17,755	3,804	(6,169)
Cash flows from investing activities:
Purchases of investments, available-for-sale		(18,616)	(33,174)	(13,324)
Purchases of limited partnership interests		(7,139)
Maturities and redemptions of investments, available-for-sale	14,315	21,769	41,969	23,260
Sales of investments, available-for-sale			26,343
Capital expenditures	(1,533)	(914)	(3,603)	(620)
Other	(4)	23	(1)	(2)
Net cash provided by (used in) investing activities	12,778	(4,877)	31,534	9,314
Cash flows from financing activities:
Net proceeds from issuance of common stock	23	51	52	56
Purchase of treasury stock	(10,988)
Other	(41)		(37)	(80)
Net cash provided by (used in) financing activities	(11,006)	51	15	(24)
Net change in cash and cash equivalents	(5,554)	12,929	35,353	3,121
Cash and cash equivalents, beginning of period	29,305	59,104	23,751	26,184
Cash and cash equivalents, end of period	$ 23,751	$ 72,033	$ 59,104	$ 29,305